AllInOneNews: breast cancer

Breast Cancer Death Risk Grows With Age

Thu Feb 09 11:00:00 CST 2012

[Medical News Today, UK] A study in the February 8 edition of JAMA shows that postmenopausal women who suffer from hormone receptor-positive breast cancer have a higher death risk of breast cancer as they get older. Background information in the article states that: "Breast cancer is the leading contributor to cancer incidence and cancer mortality in women worldwide, with 1,383,500 new cases in 2008...

Gene driver for breast cancer

Sat Feb 19 14:39:42 CST 2011

[The Canadian Broadcasting Corporation] A rare but hard-to-treat form of breast cancer is driven by a newly discovered gene, researchers have found.

Essay: Breast Cancer Screening Matters, but Prevention Is the Real Goal

Mon Feb 06 22:57:18 CST 2012

[The New York Times] Perhaps too much emphasis is placed on looking for existing breast cancer when the search should focus on prevention and the possibility of finding a vaccine.

Well Blog: A Better Way to Spend Breast Cancer Funds?

Tue Feb 07 11:43:25 CST 2012

[The New York Times] We must move breast cancer advocacy to the next level, beyond screening for cancers that are already there, even beyond the cure, to finding the cause, writes Dr. Susan Love.

Women Born To Older Mothers Have A Higher Risk Of Developing Breast Cancer

Wed Feb 08 02:00:00 CST 2012

[Medical News Today, UK] A new study analyses the influence that certain birth and infancy characteristics have on mammographic density - an important indicator of breast cancer risk. The results reveal that women born to mothers aged over 39 years and women who were taller and thinner than the average girl prior to puberty have a higher breast density. This brings with it an increased risk of developing breast cancer...

A Particular Breast Cancer Subtype May Respond To Drugs Targeting Chromosomal Instability

Tue Feb 07 03:00:00 CST 2012

[Medical News Today, UK] Another layer in breast cancer genetics has been peeled back. A team of researchers at Jefferson's Kimmel Cancer Center (KCC) led by Richard G. Pestell, M.D., PhD...

More Accurate Diagnosis, Prognosis In Challenging Breast Cancer Cases Provided By PET Techniques

Wed Feb 08 02:00:00 CST 2012

[Medical News Today, UK] In two new studies featured in the February issue of The Journal of Nuclear Medicine, researchers are revealing how molecular imaging can be used to solve mysteries about difficult cases of breast cancer...

Musculoskeletal Side Effects From Breast Cancer Treatment Are Not Long Term

Tue Jan 24 12:00:00 CST 2012

[Medical News Today, UK] Around 75% of the 48,000 women annually diagnosed with breast cancer in the UK suffer from an estrogen receptor positive tumor, which implies the involvement of the hormone estrogen in cancer growth...

Breast cancer kills older women more often

Tue Feb 07 10:39:25 CST 2012

[Reuters] NEW YORK (Reuters Health) - Breast cancer is often considered more deadly among younger women, but a new study shows older women are actually more likely to die of the disease.

Roche breast cancer drug gets FDA priority review

Tue Feb 07 07:15:26 CST 2012

[Reuters] (Reuters) - Health regulators granted a priority review for an experimental Roche breast cancer drug that in clinical trials added six months to the time before the disease worsened.

Deodorant Preservative Found In Breast Tissue From Cancer Patients

Sat Jan 14 02:00:00 CST 2012

[Medical News Today, UK] A new study led by the University of Reading in the UK that examined breast tissue samples from 40 women who underwent mastectomies for breast cancer, found they contained widespread traces of parabens, preservatives commonly used in deodorants, make-up, body lotions, moisturisers and many other cosmetic products...

Scriptaid Revives Breast Cancer Treatment Receptivity

Wed Jan 18 12:00:00 CST 2012

[Medical News Today, UK] A study by researchers from the Sbarro Institute for Cancer Research and Molecular Medicine, reveals that despite the effectiveness of endocrine therapy for breast cancer, responsiveness to the treatment depends on expression of estrogen receptors in breast cancer cells. However, Dr...

Breast Cancer Drug Abandoned By 36% Of Patients Due To Side Effects

Mon Dec 12 03:00:00 CST 2011

[Medical News Today, UK] 36% of post-menopausal breast cancer patients who take aromatase inhibitors do not complete their treatment, because the drug's side effects are so unpleasant, researchers from the Northwestern University Feinberg School of Medicine reported at the San Antonio Breast Cancer Symposium...

No Breast Cancer Protections From Soy Isoflavone Supplements

Tue Feb 07 02:00:00 CST 2012

[Medical News Today, UK] Soy isoflavone supplements did not decrease breast cancer cell proliferation in a randomized clinical trial, according to a study published in Cancer Prevention Research, a journal of the American Association for Cancer Research. Lead researcher Seema A. Khan, M.D., professor of surgery at the Robert H...

Breast Cancer Drug Exemestane Causes Substantial Bone Loss

Mon Feb 06 20:00:00 CST 2012

[Medical News Today, UK] A recent study published in The Lancet Oncology shows how exemestane (Aromasin), a drug that prevents the development of breast cancer in postmenopausal women, may significantly worsen age-related bone loss. As an aromatase inhibitor, exemestane works by blocking the synthesis of estrogen, slowing down the growth of cancers that have estrogen receptors...

Komen executive quits as questions persist

Wed Feb 08 00:11:00 CST 2012

[Los Angeles Times] As Karen Handel, the executive at the center of the funding controversy, steps down, questions continue about the breast cancer foundation's salaries, legal strategies and ties with certain products.The Susan G. Komen for the Cure foundation took another step toward rehabilitating its standing in the breast cancer community with the resignation of the executive at the center of the Planned Parenthood funding controversy.

Side Effects Of Breast Cancer Drugs Can Be So Bad Women End Treatment And Risk Return Of Cancer

Mon Dec 12 03:00:00 CST 2011

[Medical News Today, UK] Why do so many postmenopausal women who are treated for estrogen-sensitive breast cancer quit using drugs that help prevent the disease from recurring? The first study to actually ask the women themselves -- as well as the largest, most scientifically rigorous study to examine the question -- reports 36 percent of women quit early because of the medications' side effects, wh...

Komen reverses decision to deny funding to Planned Parenthood

Fri Feb 03 17:38:00 CST 2012

[Los Angeles Times] After three days of criticism from politicians and other nonprofits, the breast cancer foundation Susan G. Komen for the Cure says it will reinstate funding to Planned Parenthood.After three days of tumult, the breast cancer foundation Susan G. Komen for the Cure announced it had reversed its decision to deny further grants to Planned Parenthood Federation of America for breast-health services.

Komen reverses course

Sun Feb 05 21:50:12 CST 2012

[CNN.com International] Susan Candiotti reports on the breast cancer charity's off-again, on-again relationship with Planned Parenthood.

Susan G. Komen Starts U-Turn After Planned Parenthood Cut-Off

Fri Feb 03 13:00:00 CST 2012

[Medical News Today, UK] After announcing that it was going to cut funding for Planned Parenthood's breast screenings, Susan G. Komen for the Cure, a breast cancer foundation, today announced that it is changing its funding criteria, meaning it will probably resume funding to Planned Parenthood, a sexual health organization. The public outcry regarding alleged reasons for Planned Parenthood being dropped as a grantee by Komen appears to have taken the breast cancer charity by surprise...

Op-Ed Columnist: The Politics of Absolutely Everything

Sat Feb 04 00:43:03 CST 2012

[International Herald Tribune, France] With that big political dust-up about breast cancer this week, we've clearly hit the point where there's nothing that can't be divided into red state/blue state.

Exemestane, Thought to Prevent Cancer, Also Causes Bone Loss

Tue Feb 07 02:05:48 CST 2012

[The New York Times] A drug that scientists had hoped would help prevent breast cancer has a significant side effect.

The Genetic Outlier

Fri Feb 10 15:15:49 CST 2012

[WSJ.com, The Wall Street Journal] Through the story of a young Hispano woman who died of breast cancer, "The Wandering Gene and the Indian Princess" explores the intersection of modern genetics and cultural history. Charles C. Mann reviews.

Official quits breast cancer charity over dispute

Tue Feb 07 09:42:17 CST 2012

[USATODAY.com] An executive with a major U.S. breast-cancer charity has resigned after a dispute over funding for the best-known family planning organizati ...

Opinion: Teaching moment on Komen

Tue Feb 07 18:17:45 CST 2012

[CNN.com International] Samantha King says now that we all realize that foundations, like Komen for the Cure, trade in influence and politics, can we direct new attention to finding directing that towards real progress fighting breast cancer?

Generic breast cancer prevention drug overlooked

Tue Feb 07 15:31:01 CST 2012

[The Canadian Broadcasting Corporation]

Relatively few postmenopausal women at high risk for breast cancer are taking a generic drug proven to reduce the disease's occurrence.

Planned Parenthood breast-screening grant restored

Fri Feb 03 16:54:29 CST 2012

[The Canadian Broadcasting Corporation]

After three days of controversy, a renowned breast cancer charity in the U.S. said Friday it is reversing its decision to cut breast-screening grants to the country's most well-known reproductive health organization.

Astronaut Janice Voss dies in Arizona

Tue Feb 07 13:20:52 CST 2012

[Reuters] (Reuters) - Former Astronaut Janice E. Voss, one of the few women launched into space, has died of breast cancer in Arizona, her alma mater said on Tuesday.

Most women with cancer want a role in decisions

Thu Feb 09 12:36:48 CST 2012

[Reuters] NEW YORK (Reuters Health) - About two-thirds of women diagnosed with early stage breast cancer want to take part in making decisions about their treatment, according to a new survey of patients from five different countries.

U.S. group reverses funding decision

Fri Feb 03 15:42:36 CST 2012

[CNN.com International] Faced with a deluge of opposition that included pressure from lawmakers and internal dissent, one of America's leading breast cancer advocacy groups on Friday reversed itself on a decision that would have cut off funding to some Planned Parenthood projects.

G.E. Ends Bid to Create a Supply of Technetium 99m

Tue Feb 07 00:46:13 CST 2012

[The New York Times] Continued obstacles plague the effort to provide a reliable supply of technetium 99m, a radioisotope crucial to identifying heart and kidney disease and assisting in breast cancer surgery.

Tykerb And Herceptin - Their Role In Breast Cancer Treatment Clarified

Thu Jan 19 10:00:00 CST 2012

[Medical News Today, UK] Patients with HER2-positive breast cancer have been treated with Tykerb (lapatinib) both in combination with herceptin (trastuzumab), and as an alternative single-agent therapy for pre-surgery (neo-adjuvant) chemotherapy...

Karen Handel Exits Susan G. Komen: The Resignation Letter

Tue Feb 07 10:59:57 CST 2012

[Forbes] This morning Karen Handel, Susan G. Komen's controversial vice president of public policy announced this morning that she would resign from the breast cancer charity and would decline any offer of a severance package.

Partial Mastectomies Often Result In Further Surgeries

Fri Feb 03 13:00:00 CST 2012

[Medical News Today, UK] According to an investigation in the February 1 issue of JAMA, surgery to remove additional tissue (reexcision) is required in almost 1 in 4 women who undergo a partial mastectomy for breast cancer treatment. In addition, there is considerable surgeon and institutional difference in the rate of reexcisions that have nothing to do with patients' characteristics. In the U.S...

Komen Foundation reverses funding decision of Planned Parenthood

Sat Feb 04 07:08:04 CST 2012

Komen exec quits after Planned Parenthood flap

Tue Feb 07 13:24:49 CST 2012

[Associated Press] ATLANTA (AP) -- An executive at the Susan G. Komen for the Cure breast cancer charity resigned Tuesday over her support to strip Planned Parenthood of funding, but disputed that she was the driving force behind the decision that created a firestorm of criticism last week....

Komen advisor steps down after Planned Parenthood flap

Tue Feb 07 04:50:46 CST 2012

[Reuters] (Reuters) - A senior advisor to the breast cancer charity Susan G. Komen for the Cure has resigned in the wake of a public outcry over the group's decision to cut funding to Planned Parenthood, which provides birth control and abortion services.

Preoperative Breast Cancer Treatment May Be Improved By Combining 2 Anti-HER2 Drugs

Tue Jan 17 04:00:00 CST 2012

[Medical News Today, UK] Using two drugs that inhibit the growth factor HER2 for preoperative treatment of early-stage HER2-positive breast cancer appears to have better results than treatment with a single agent...

The Genome And The Timing Of Menopause

Tue Jan 24 04:00:00 CST 2012

[Medical News Today, UK] An international team of researchers has discovered 13 new regions of the genome associated with the timing of menopause. These genes shed light on the biological pathways involved in reproductive lifespan and will provide insights into conditions connected to menopause, such as breast cancer and heart disease...

More Adverse Quality-Of-Life Issues Experienced By Younger Breast Cancer Patients

Tue Jan 24 02:00:00 CST 2012

[Medical News Today, UK] Younger women with breast cancer experience a decrease in their health-related quality of life (QOL), associated with increased psychological distress, weight gain, a decline in their physical activity, infertility and early onset menopause, according to a study published in the Journal of the National Cancer Institute...

Has Komen Shot Itself In The Foot?

Sun Feb 05 16:00:00 CST 2012

[Medical News Today, UK] Susan G. Komen for the Cure, a breast cancer charity which until recently had an enviable reputation as being totally impartial and focused purely on saving women's lives, may have caused itself irreparable damage. By announcing a few days ago that it would stop awarding funds to Planned Parenthood, a sexual health organization; it found itself in the middle of an enormous public outcry...

How Early Breast Tumors Become Deadly

Fri Feb 10 02:00:00 CST 2012

[Medical News Today, UK] Researchers have discovered a restricted pattern of molecules that differentiate early-stage breast tumors from invasive, life-threatening cancer. They also found a similar molecular signature that correlated with the aggressiveness of invasive tumors, and with the time to metastasis and overall survival. Researchers at the Ohio State University Comprehensive Cancer Center - Arthur G...

Insight: Komen charity under microscope for funding, science

Wed Feb 08 06:22:40 CST 2012

[Reuters] NEW YORK (Reuters) - The Susan G. Komen for the Cure charity defines its mission as finding a cure for breast cancer. In recent years, however, it has cut by nearly half the proportion of fund-raising dollars it spends on grants to scientists working to understand the causes and develop effective new treatments for the disease.

Performing And Teaching Breast Examinations For Early Breast Cancer Detection

Sun Nov 20 02:00:00 CST 2011

[Medical News Today, UK] MammaCare, a revolutionary tool that has set standards for teaching women and clinicians how to perform clinical breast exams, is training professionals around the country to detect lumps earlier and save lives. Widely-publicized statistics inform women about the importance of early detection of cancer...

Chemotherapy During Pregnancy Does Not Risk The Child's General Health

Fri Feb 10 16:00:00 CST 2012

[Medical News Today, UK] A recent study published by the The Lancet Oncology indicates that children of women who received chemotherapy during their pregnancy suffer no adverse effects, developing as well as children in the general population. The study was led by Dr FrÃ©dÃ©ric Amant, Multidisciplinary Breast Cancer Center, Leuven Cancer Institute, Katholieke Universiteit Leuven, Belgium...

Similarities Between Genetic Signatures In Developing Organs And Breast Cancer Could Predict And Personalize Cancer Therapies

Fri Feb 10 02:00:00 CST 2012

[Medical News Today, UK] Reviving a theory first proposed in the late 1800s that the development of organs in the normal embryo and the development of cancers are related, scientists at the Salk Institute for Biological Studies have studied organ development in mice to unravel how breast cancers, and perhaps other cancers, develop in people...

Mindfulness-Based Stress Reduction Benefits Breast Cancer Survivors

Wed Jan 04 02:00:00 CST 2012

[Medical News Today, UK] Women recently diagnosed with breast cancer have higher survival rates than those diagnosed in previous decades, according to the American Cancer Society. However, survivors continue to face health challenges after their treatments end. Previous research reports as many as 50 percent of breast cancer survivors are depressed...

Antiestrogen Supplements Might Reduce Melanoma Risk

Sun Jan 08 02:00:00 CST 2012

[Medical News Today, UK] According to an investigation published in Cancer Prevention Research, a journal of the American Association for Cancer Research, antiestrogen supplements may lower the risk of women with breast cancer developing melanoma. The Swiss Research Foundation against Cancer, a nonprofit group, funded the investigation...

Susan G. Komen foundation takes steps to rebuild trust after PR fiasco

Sat Feb 04 19:45:00 CST 2012

[The Washington Post] The nation's leading breast cancer advocacy group has gone into full damage-control mode.Executives of the embattled Susan G. Komen for the Cure foundation held conference calls with affiliates Saturday to discuss a new strategy for working with supporters, a first step in rebuilding trust after this week's public relations fiasco surrounding Komen's off-then-on-again decision to fund Planned Parenthood.Read full article >>

Soy Isoflavone Supplementation Not Effective In Breast Cancer Protection

Wed Feb 08 12:00:00 CST 2012

[Medical News Today, UK] A study published in Cancer Prevention Research, a journal of the American Association for Cancer Research, reveals that breast cancer cell proliferation was not lowered with soy isoflavone supplements in a randomized human trial. Isoflavone are components of soy foods believed to have anti-estrogen activity...

Susan G. Komen for the Cure founder defends Planned Parenthood decision

Fri Feb 03 00:45:00 CST 2012

[Los Angeles Times] Nancy G. Brinker says abortion is not the reason that grants for breast cancer exams are being cut off. Lawmakers, women's health advocates and others continue to criticize the move, and both groups see donations pour in.As the backlash grew against the decision by Susan G. Komen for the Curefoundation to cease awarding grants to Planned Parenthood, Komen officials ended two days of silence on Thursday and tried to manage the uproar.

Zinc Control Mechanisms Could Be Key To Aggressive Breast Cancer Treatments

Wed Feb 08 02:00:00 CST 2012

[Medical News Today, UK] The body's control mechanisms for delivering zinc to cells could be key to improving treatment for some types of aggressive breast cancer. New research by Cardiff University and King's College London has identified the switch which releases zinc into cells, with important implications for a number of diseases. Zinc has long been known to play a vital part in human health...

Body Absorbs Breast Implant During Pilates Session

Fri Dec 16 12:00:00 CST 2011

[Medical News Today, UK] A breast cancer survivor's breast implant was swallowed up by her own body during a Pilates session, resulting in surgical intervention to retrieve it and place it back into the breast, according to an article by doctors at Johns Hopkins' University and published in NEJM (New England Journal of Medicine). The 59-year-old female had undergone a double mastectomy, followed by breast implants...

FDA commits to quick review of new Genentech breast cancer drug

Tue Feb 07 12:23:41 CST 2012

[Bizjournals] Genentech Inc.'s next-generation breast cancer drug will get priority review from the Food and Drug Administration.The South San Francisco-based U.S. unit of drug giant Roche Group said Tuesday that the FDA said it would make a decision about the drug, called pertuzumab, by June 8.Pertuzumab is a humanized monoclonal antibody designed to prevent the HER2 receptor ' or human epidermal growth factor receptor 2, which promotes the growth of cancer cells ' from pairing with other HER receptors...